A new study has highlighted a growing public health concern: declining newborn vaccination coverage for Hepatitis B could significantly increase infection rates among infants, especially those born to unscreened mothers.
The research, conducted by experts at Boston Medical Center and Boston University School of Public Health, was published in JAMA Pediatrics. It used simulation modeling to understand how vaccination and maternal screening together influence infant health outcomes in the United States.
Why Hepatitis B Prevention at Birth Matters
Hepatitis B infection acquired at birth or during early infancy can lead to lifelong complications, including chronic liver disease. While prenatal screening is recommended, the study notes that about 12% to 16% of pregnant individuals in the U.S. are not screened for the virus.
This gap leaves many newborns vulnerable. In such cases, the birth dose of the hepatitis B vaccine acts as a critical safety net, protecting infants even when the mother’s infection status is unknown.
ALSO READ: 32 Practical Ways to Motivate Yourself to Work Out (And Actually Stick to It)
Key Findings From the Study
The study found a strong link between vaccination coverage and infection risk. When vaccination rates among infants born to unscreened mothers dropped to around 10% — similar to levels seen during a brief pause in recommendations in 1999 — researchers projected more than 1,000 additional infections.
However, when vaccination coverage increased to 80%, which aligns with current universal birth dose practices, the number of additional infections dropped dramatically to just over 100. This represents nearly a tenfold reduction in risk.
Margaret Lind, Ph.D., emphasized that hepatitis B prevention is highly sensitive to changes in vaccination rates. Even small declines can lead to a noticeable rise in infections, particularly among high-risk groups.
Screening Alone Isn’t Enough
The research also explored whether improving maternal screening could compensate for lower vaccination rates. The findings suggest that screening would need to reach about 98% nationwide to match the protection offered by high vaccination coverage — a level that is currently unrealistic.
Dr. Rachel Epstein, an infectious disease specialist involved in the study, noted that relying solely on screening is not sufficient. Consistent vaccination at birth remains essential to prevent transmission and protect newborns.
A Clear Public Health Message
The study reinforces a simple but critical point: maintaining high newborn vaccination coverage is one of the most effective ways to prevent hepatitis B infections. With gaps still present in prenatal screening, the birth dose vaccine serves as a vital layer of protection for infants across the country.
As health systems continue to improve screening practices, experts stress that vaccination efforts must remain strong and consistent to reduce long-term health risks.
📩 For more studies. Subscribe to the JournalTodays Newsletter for the latest delivered straight to your inbox.
